These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27074235)

  • 1. Compatibility: drugs and parenteral nutrition.
    Miranda TM; Ferraresi Ade A
    Einstein (Sao Paulo); 2016; 14(1):52-5. PubMed ID: 27074235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixing and compatibility guide for commonly used aerosolized medications.
    Burchett DK; Darko W; Zahra J; Noviasky J; Probst L; Smith A
    Am J Health Syst Pharm; 2010 Feb; 67(3):227-30. PubMed ID: 20101066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.
    Staven V; Waaseth M; Wang S; Grønlie I; Tho I
    PDA J Pharm Sci Technol; 2015; 69(2):270-83. PubMed ID: 25868993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs.
    Veltri M; Lee CK
    Am J Health Syst Pharm; 1996 Nov; 53(21):2611-3. PubMed ID: 8913390
    [No Abstract]   [Full Text] [Related]  

  • 6. A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration.
    Beiler B; Vigneron J; D'Huart E; Demoré B
    Eur J Hosp Pharm; 2024 Aug; 31(5):461-467. PubMed ID: 36941001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit.
    Gikic M; Di Paolo ER; Pannatier A; Cotting J
    Pharm World Sci; 2000 Jun; 22(3):88-91. PubMed ID: 11028261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral nutrition compatibility and stability: Practical considerations.
    Boullata JI; Salman G; Mirtallo JM; Canada TW; Monczka J; Gura KM; Kiritsy P
    Nutr Clin Pract; 2024 Oct; 39(5):1150-1163. PubMed ID: 38994914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 11. Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
    Campos-Baeta Y; Saavedra-Mitjans M; Garin N; Cardenete J; Cardona D; Riera P
    Nutr Clin Pract; 2020 Oct; 35(5):967-972. PubMed ID: 31482649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures.
    Puzovic M; Hardy G
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):311-7. PubMed ID: 17414500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of 5-fluorouracil and total parenteral nutrition solutions.
    Hardin TC; Clibon U; Page CP; Cruz AB
    JPEN J Parenter Enteral Nutr; 1982; 6(2):163-5. PubMed ID: 6808179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous administration of drugs and artificial nutrition: practical aspects].
    Pérez Peiró C; Martínez Martínez MA; Jiménez Torres NV
    Nutr Hosp; 1990; 5(4):217-24. PubMed ID: 2127715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method to obtain and present complete information on the compatibility: study of its validity for eight binary mixtures of morphine with drugs frequently used in palliative care.
    Vermeire A; Remon JP; Schrijvers D; Demeulenaere P
    Palliat Med; 2002 Sep; 16(5):417-24. PubMed ID: 12380660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review.
    Castells Lao G; Rodríguez Reyes M; Roura Turet J; Prat Dot M; Soy Muner D; López Cabezas C
    Med Intensiva (Engl Ed); 2020 Mar; 44(2):80-87. PubMed ID: 30262380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compatibility of intravenous medications needs attention. Catheter occlusion, treatment failure and embolisms can be prevented].
    Colldén H; Teimori K; Asadian R
    Lakartidningen; 2015 Nov; 112():. PubMed ID: 26556450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual compatibility of 30 additives with a parenteral nutrient solution.
    Athanikar N; Boyer B; Deamer R; Harbison H; Henry RS; Jurgens R; Mett C; Sturgeon R; VanLeuven M; Welco A
    Am J Hosp Pharm; 1979 Apr; 36(4):511-3. PubMed ID: 107797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.